External Event - 29th Sep 2021
Time - 6:00 AM - 7:00 AM BST
Fernando Maestú will discuss a series of studies, which mainly used MEG to record the resting-state activity and a memory task in patients with Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD), and in healthy subjects at preclinical stage or at risk for developing dementia. All these findings together indicate that hyper synchronization of the brain networks could be an excellent non-invasive biomarker for tracking the disease and evaluate interventions.
Agenda:
1. Brief introduction to the history of MEG in Alzheimer's Disease
2. Why MEG?
3. MEG clinical studies in early stages of AD (MCI and SCD)
4. MEG profiles of MCI converters versus non-converters
5. MEG profiles in combination with amyloid, tau and APOE4
6. Is there a chance for improving the brain network? Physical activity, cognitive training and diet as a potential non-pharmacological intervention
7. How these MEG profiles are in association of findings found in animal models and computational neuroscience studies.
8. Conclusions
